Novo Nordisk
NVO
#97
Rank
โ‚น16.299 T
Marketcap
โ‚น3,655
Share price
3.11%
Change (1 day)
-45.98%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.799 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.738 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.897 T9.13%
2024 โ‚น1.738 T22.84%
2023 โ‚น1.415 T57.81%
2022 โ‚น896.98 B5.24%
2021 โ‚น852.35 B12.38%
2020 โ‚น758.44 B13.11%
2019 โ‚น670.54 B-3.45%
2018 โ‚น694.50 B1.88%
2017 โ‚น681.66 B4.3%
2016 โ‚น653.54 B10.32%
2015 โ‚น592.39 B7.47%
2014 โ‚น551.23 B3.4%
2013 โ‚น533.10 B19.09%
2012 โ‚น447.65 B15.58%
2011 โ‚น387.32 B16.58%
2010 โ‚น332.24 B25.66%
2009 โ‚น264.40 B10.68%
2008 โ‚น238.90 B55.82%
2007 โ‚น153.32 B7.02%
2006 โ‚น143.26 B19.05%
2005 โ‚น120.33 B10.55%
2004 โ‚น108.85 B
2002 โ‚น76.53 B-14.39%
2001 โ‚น89.39 B-52.82%
2000 โ‚น189.47 B250%
1999 โ‚น54.13 B31.21%
1998 โ‚น41.25 B34.31%
1997 โ‚น30.71 B11.46%
1996 โ‚น27.55 B9.03%
1995 โ‚น25.27 B-3.15%
1994 โ‚น26.09 B-0.67%
1993 โ‚น26.27 B45.38%
1992 โ‚น18.07 B-13.81%
1991 โ‚น20.96 B37.12%
1990 โ‚น15.29 B-0.79%
1989 โ‚น15.41 B26.2%
1988 โ‚น12.21 B24.97%
1987 โ‚น9.77 B-0.9%
1986 โ‚น9.86 B-7.78%
1985 โ‚น10.69 B24.87%
1984 โ‚น8.56 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.088 T-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.067 T 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น836.08 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น738.03 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA